At Tata Consumer Products, Das drives growth strategy, outcomes and profit & loss for the packaged beverages category in ...

Following Pfizer's disposal, BlackRock Investment Management (UK) Ltd, a unit of BlackRock, will become Haleon's largest ...

The rebrand comes after GSK transferred its consumer health business to Haleon to focus on innovative drugs. Haleon will now encompass consumer health brands including Sensodyne, Panadol, Eno, and ...

GSK's consumer health spinout Haleon started trading ... in a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers, and ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...